This program aimed to strengthen multidisciplinary competence in interpreting gene expression and recurrence risk scores alongside clinicopathological factors, with a focus on multidisciplinary decision-making to optimize adjuvant treatment strategies and personalize patient care.
"Thank you so much for the invitation and the excellent organization of the event. It was a great honor to be part of this group and to discuss with so many distinguished experts. The professional exchange was very enriching."
Elena-Diana Chiru, Faculty
Expert-led MDT collaboration
- This IME program brought together a multidisciplinary tumor board (MTB) of top experts to analyze real-world breast cancer cases “live.”
- Faculty modeled real-world multidisciplinary decision-making, demonstrating integration of molecular and clinicopathological data into personalized treatment strategies.
- The event demonstrated how interactive, expert-led live meetings can enhance clinician competence in applying molecular diagnostics to personalize therapy.
Interactive learner engagement
- Real-time polling questions to test knowledge and decision-making.
- Pre- and post-event knowledge checks to measure learning gains.
- Q&A sessions allowing learners to submit real-world cases and questions for faculty discussion.
Faculty and learner feedback alike demonstrated appreciation of the “excellent” and “innovative” program
- In both live and on-demand formats, learners rated the quality of the program of 95% or higher.
- “Excellent program, thank you very much. Please keep it up!” – Learner
Strong learner gains were observed as a result
- +25% improved understanding of the predictive role of the 21-gene RS compared to gene scoring arrays that have purely prognostic value.
- +42% increased knowledge of guideline-recommended RS thresholds to support adjuvant therapy decisions based on nodal and menopausal status.
- +20% stronger intention to regularly involve a molecular tumor board in decision-making for early HR+/HER2‑ breast cancer.
“[This meeting was] the concept of the future!"
Marc Thill, Chair
Program formats
Multidiscplinary tumor board live streamed
Faculty
Chair: Prof. Dr. med. Nadia Harbeck and Prof. Dr. med. Marc Thill Prof. Dr. Beyhan Ataseven, Dr. Steffi Busch, Dr. Elena-Diana Chiru, Prof. Dr. Diana Lüftner, Prof. Dr. Sven Perner, Prof. Dr. Michael Untch, Esther Wiedemann
Target audience
Gynecologists from university hospitals and private practices, pathologists, and specialized nursing professionals in Germany and Switzerland.
